Lifestyle Intervention in Obesity, Effect on Diabetes

NCT ID: NCT00466362

Last Updated: 2024-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2007-04-30

Study Completion Date

2008-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There are evidence from numerous studies on effect of lifestyle intervention in morbidly obese patients with type 2 diabetes. This study examines the effect of the "Evje-model" on type 2 diabetes.

The "Evje-model" is a combined 12 months model, consisting of repeated stays in a specialist centre, telephone follow-up at home, home groups, self monitoring and close contact with the patients' local physician.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

There will be done QOL-measures, blood- and urine analysis, weight, waist- and hip measurement, blood pressure and VO2-max measurement at baseline, after 6 months and after 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The Evje Model

Lifestyle intervention

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with BMI \> 35 with diagnosed type 2 diabetes
* Referred to Lifestyle Intervention from a public hospital

Exclusion Criteria

* Pregnancy
* Active major psychiatric disease(s)
* Active and serious eating disorder
* Drug- and/or alcohol dependency
Minimum Eligible Age

18 Years

Maximum Eligible Age

67 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tor-Ivar Karlsen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tor-Ivar Karlsen

RN

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tom B Schulz, Dr. Med.

Role: PRINCIPAL_INVESTIGATOR

Evjeklinikken

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Evjeklinikken AS

Evje Og Hornnes, Evjemoen, Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EK0702

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Evaluation of Health and Lifestyle Tool
NCT04691973 ACTIVE_NOT_RECRUITING
Evaluation of Lifestyle Tool in Type 2 Diabetes
NCT05679115 ACTIVE_NOT_RECRUITING NA
Live Your Life Without Diabetes
NCT03663803 COMPLETED NA
Diabetes Prevention In Estrie
NCT00991549 COMPLETED NA
Assessment of the Health and Lifestyle Tool
NCT04624321 ACTIVE_NOT_RECRUITING NA
Prevention With the Health and Lifestyle Tool
NCT05006508 ACTIVE_NOT_RECRUITING NA